arrow_back Back to App

PrEP and PEP Access Act: Free HIV Prevention Medication

This act aims to increase access to HIV prevention medications (PrEP and PEP) by ensuring their free access through health insurance (private, federal, Medicaid, CHIP, VA, DOD, IHS) and prohibiting discrimination in life, disability, and long-term care insurance based on the use of these medications. It also establishes public and provider education campaigns and grant programs for states and organizations.
Key points
Free access to PrEP and PEP medications and related tests and doctor visits under most health insurance plans.
Prohibition of prior authorization requirements for PrEP drugs in private insurance if a therapeutically equivalent drug is available without such a requirement.
Prohibition of discrimination in life, disability, and long-term care insurance based on the use of HIV prevention medications.
Funding for grant programs for states and organizations to increase access to PrEP and PEP, especially for uninsured and underinsured individuals.
Public and provider education campaigns to increase awareness of PrEP and PEP and combat stigma.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6117
Sponsor: Rep. Schiff, Adam B. [D-CA-28]
Process start date: 2021-12-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-04-17
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PrEP Access and Coverage Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6117.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-12-01.

What are the main provisions?

Key points include:

  • Free access to PrEP and PEP medications and related tests and doctor visits under most health insurance plans.
  • Prohibition of prior authorization requirements for PrEP drugs in private insurance if a therapeutically equivalent drug is available without such a requirement.
  • Prohibition of discrimination in life, disability, and long-term care insurance based on the use of HIV prevention medications.
  • Funding for grant programs for states and organizations to increase access to PrEP and PEP, especially for uninsured and underinsured individuals.
  • Public and provider education campaigns to increase awareness of PrEP and PEP and combat stigma.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Schiff, Adam B. [D-CA-28].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health